SCHEMBL1023295

SCHEMBL1023295

O=C(O)C1CCC(c2cc(O)n3nccc3n2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 6/20 0.42
PDE4A P27815 5/20 0.42
PDE4B Q07343 5/20 0.42
PDE4C Q08493 5/20 0.42
PDE10A Q9Y233 1/20 0.39
CDK2 P24941 2/20 0.39
CCNA1 P78396 2/20 0.39
CHEK1 O14757 1/20 0.39
CCNA2 P20248 1/20 0.39
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
POLB P06746 2/20 0.36
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CCNT1 O60563 1/20 0.35
CDK9 P50750 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16086901 0.85 PDE10A (0.48) PDE4DPDE4APDE4BPDE4CPDE10A
SCHEMBL1075532 0.85 CDK2 (0.55) PDE4DPDE4APDE4BPDE4CPDE10A
SCHEMBL2679820 0.85 PDE10A (0.41) PDE10ACDK2CCNA1CHEK1CCNA2
SCHEMBL10236624 0.85 PDE10A (0.41) PDE10ACDK2CCNA1CHEK1CCNA2
SCHEMBL29152851 0.83 CDK2 (0.50) PDE10ACDK2CCNA1CHEK1CCNA2
SCHEMBL584533 0.83 HPGD (0.39) PDE10ACDK2CCNA1CHEK1CCNA2
SCHEMBL6893617 0.82 PDE10A (0.37) PDE10ACDK2CCNA1CHEK1CCNA2
SCHEMBL1024592 0.82 PDE10A (0.37) PDE10ACDK2CCNA1CHEK1CCNA2
SCHEMBL12953163 0.81 CDK2 (0.49) PDE10ACDK2CCNA1CHEK1CCNA2
SCHEMBL10236617 0.80 CDK9 (0.38) PDE10ACDK2CCNA1CHEK1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448942-A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS Schering Corporation (US) 2012-05-09 EP disclosed
WO-2011002887-A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS SCHERING CORPORATION (US) 2011-01-06 WO disclosed